CTX330
DEAD

Serial Number

97469034

Owner

CRISPR Therapeutics AG

Attorney

Tiffany D. Gehrke

Filing Date

Jun 21, 2022

Add to watchlist:

No watchlists yet
View on USPTO

CTX330 Trademark

Serial Number: 97469034

CTX330 is a trademark filed by CRISPR Therapeutics AG on June 21, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

CRISPR Therapeutics AG (50 trademarks)

ZUG V8 6300 , CH

Entity Type: 99

Trademark Details

Filing Date

June 21, 2022

Registration Date

Not Registered

Published for Opposition

April 23, 2024

Goods & Services

Cells for medical or clinical use in the field of in vivo gene editing therapy for the treatment of cardiovascular diseases; pharmaceutical and biopharmaceutical agents for the treatment of cardiovascular disease in the field of in vivo gene editing therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cardiovascular disease in the field of in vivo gene editing therapy

Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of in vivo gene editing therapy

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 20, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 20, 2025 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 18, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 23, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 23, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 3, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 16, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 27, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 27, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 27, 2024 ERFR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 18, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 18, 2023 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 2, 2023 GNFN
FINAL REFUSAL E-MAILED
Oct 2, 2023 GNFR
FINAL REFUSAL WRITTEN
Oct 2, 2023 CNFR
ASSIGNED TO EXAMINER
Sep 19, 2023 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 10, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 9, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 9, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 9, 2023 GNRN
NON-FINAL ACTION E-MAILED
May 9, 2023 GNRT
NON-FINAL ACTION WRITTEN
May 9, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 31, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 8, 2022 NWOS
NEW APPLICATION ENTERED
Jun 24, 2022 NWAP